These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29502481)

  • 1. A Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit.
    Masood U; Sharma A; Bhatti Z; Carroll J; Bhardwaj A; Sivalingam D; Dhamoon AS
    Inquiry; 2018; 55():46958018759116. PubMed ID: 29502481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
    Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
    Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
    Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
    Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of an electronic medical record-based alarm in the optimization of stress ulcer prophylaxis.
    Saad EJ; Bedini M; Becerra AF; Martini GD; Gonzalez JG; Bolomo A; Castellani L; Quiroga S; Morales C; Leathers J; Balderramo D; Albertini RA
    Gastroenterol Hepatol; 2018; 41(7):432-439. PubMed ID: 29895412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency.
    Mousavi M; Dashti-Khavidaki S; Khalili H; Farshchi A; Gatmiri M
    Int J Pharm Pract; 2013 Aug; 21(4):263-9. PubMed ID: 23418812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication reconciliation effect on prolonged inpatient stress ulcer prophylaxis.
    Zeigler AJ; McAllen KJ; Slot MG; Barletta JF
    Ann Pharmacother; 2008 Jul; 42(7):940-6. PubMed ID: 18577762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pharmacy resident led education on resident physician prescribing habits associated with stress ulcer prophylaxis in non-intensive care unit patients.
    Agee C; Coulter L; Hudson J
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S48-52. PubMed ID: 25991596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.
    Hong MT; Monye LC; Seifert CF
    Ann Pharmacother; 2015 Sep; 49(9):1004-8. PubMed ID: 26139638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do physicians prescribe stress ulcer prophylaxis to general medicine patients?
    Hussain S; Stefan M; Visintainer P; Rothberg M
    South Med J; 2010 Nov; 103(11):1103-10. PubMed ID: 21042168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
    Thomas L; Culley EJ; Gladowski P; Goff V; Fong J; Marche SM
    J Manag Care Pharm; 2010 Mar; 16(2):122-9. PubMed ID: 20178397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of A Collaborative Strategy to Reduce the Inappropriate Use of Acid Suppressive Therapy in Non-Intensive Care Unit Patients.
    Belfield KD; Kuyumjian AG; Teran R; Amadi M; Blatt M; Bicking K
    Ann Pharmacother; 2017 Jul; 51(7):577-583. PubMed ID: 28622739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Pharmacist-Led Impact on Inappropriate Albumin Use and Costs in the Critically Ill.
    Buckley MS; Knutson KD; Agarwal SK; Lansburg JM; Wicks LM; Saggar RC; Richards EC; Kopp BJ; Erstad BL
    Ann Pharmacother; 2020 Feb; 54(2):105-112. PubMed ID: 31544470
    [No Abstract]   [Full Text] [Related]  

  • 14. Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.
    Marker S; Perner A; Wetterslev J; Barbateskovic M; Jakobsen JC; Krag M; Granholm A; Anthon CT; Møller MH
    Syst Rev; 2017 Jun; 6(1):118. PubMed ID: 28646925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and factors associated with inappropriate continuation of stress ulcer prophylaxis at discharge.
    Chinnappan J; Al-Handola R; Joseph NM; Ogbon E; McDonald PJ
    BMJ Open Qual; 2024 May; 13(2):. PubMed ID: 38729753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; McArthur C; Cook D; Nielsen N; Pelosi P; Keus F; Guttormsen AB; Moller AD; Møller MH;
    Acta Anaesthesiol Scand; 2015 May; 59(5):576-85. PubMed ID: 25880349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a pharmacist-driven protocol to decrease proton pump inhibitor use in non-intensive care hospitalized adults.
    Michal J; Henry T; Street C
    Am J Health Syst Pharm; 2016 Sep; 73(17 Suppl 4):S126-32. PubMed ID: 27543598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center.
    Erstad BL; Camamo JM; Miller MJ; Webber AM; Fortune J
    Crit Care Med; 1997 Oct; 25(10):1678-84. PubMed ID: 9377882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmacy intervention on the use of proton-pump inhibitors in the hospital setting.
    Atkins R; Smith L
    Consult Pharm; 2013 Dec; 28(12):786-92. PubMed ID: 24322962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress ulcer prophylaxis: reducing non-indicated prescribing after hospital discharge.
    Hatch JB; Schulz L; Fish JT
    Ann Pharmacother; 2010 Oct; 44(10):1565-71. PubMed ID: 20841521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.